Mereo BioPharma Group PLC (MREO)
3.27
+0.10
(+3.15%)
USD |
NASDAQ |
May 16, 16:00
3.26
-0.01
(-0.31%)
After-Hours: 20:00
Mereo BioPharma Group EPS Diluted (TTM): -0.20 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.20 |
| June 30, 2023 | -0.2942 |
| December 31, 2022 | -0.367 |
| June 30, 2022 | -0.6748 |
| December 31, 2021 | -0.3374 |
| June 30, 2021 | -0.8921 |
| December 31, 2020 | -7.493 |
| June 30, 2020 | -7.625 |
| Date | Value |
|---|---|
| December 31, 2019 | -2.557 |
| June 30, 2019 | -2.688 |
| December 31, 2018 | -2.863 |
| June 30, 2018 | -3.141 |
| December 31, 2017 | -3.784 |
| June 30, 2017 | -3.400 |
| December 31, 2016 | -5.126 |
| June 30, 2016 | -3.938 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
-7.625
Minimum
Jun 2020
-0.20
Maximum
Dec 2023
-2.313
Average
-0.7834
Median
EPS Diluted (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | -402.00 |
| NuCana PLC | -16.46 |
| TC BioPharm (Holdings) PLC | -5.057 |
| Adaptimmune Therapeutics PLC | -0.4738 |
| Autolus Therapeutics PLC | -1.20 |